SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-117962
Filing Date
2024-04-26
Accepted
2024-04-26 16:03:58
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFA14A d631189ddefa14a.htm DEFA14A 21231
2 GRAPHIC g631189dsp42.jpg GRAPHIC 5062
3 GRAPHIC g631189dsp42c.jpg GRAPHIC 3741
4 GRAPHIC g631189dsp42d.jpg GRAPHIC 3092
5 GRAPHIC g631189dsp42e.jpg GRAPHIC 3001
6 GRAPHIC g631189dsp44.jpg GRAPHIC 67894
7 GRAPHIC g631189dsp44a.jpg GRAPHIC 27239
8 GRAPHIC g631189dsp44c.jpg GRAPHIC 8434
9 GRAPHIC g631189dsp44dd.jpg GRAPHIC 4880
  Complete submission text file 0001193125-24-117962.txt   193466
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39692 | Film No.: 24883490
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)